Histone modifiers in cancer: Friends or foes?

138Citations
Citations of this article
285Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Covalent modifications of histones can regulate all DNA-dependent processes. In the last few years, it has become more and more evident that histone modifications are key players in the regulation of chromatin states and dynamics as well as in gene expression. Therefore, histone modifications and the enzymatic machineries that set them are crucial regulators that can control cellular proliferation, differentiation, plasticity, and malignancy processes. This review discusses the biology and biochemistry of covalent histone posttranslational modifications (PTMs) and evaluates the dual role of their modifiers in cancer: as oncogenes that can initiate and amplify tumorigenesis or as tumor suppressors. © The Author(s) 2011.

Cite

CITATION STYLE

APA

Cohen, I., Porȩba, E., Kamieniarz, K., & Schneider, R. (2011, June). Histone modifiers in cancer: Friends or foes? Genes and Cancer. https://doi.org/10.1177/1947601911417176

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free